☰

Kathleen A. Ross, Ph.D. - Publications

Affiliations: 
Chemical and Biological Engineering Iowa State University, Ames, IA, United States 
Area:
polymer physics
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ross KA, Tingle AM, Senapati S, Holden KG, Wannemuehler MJ, Mallapragada SK, Narasimhan B, Kohut ML. Novel nanoadjuvants balance immune activation with modest inflammation: implications for older adult vaccines. Immunity & Ageing : I & A. 20: 28. PMID 37344886 DOI: 10.1186/s12979-023-00349-5  0.588
2022 Stephens LM, Ross KA, McLellan JS, Narasimhan B, Varga SM. Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model. Journal of Virology. 96: e0150222. PMID 36314826 DOI: 10.1128/jvi.01502-22  0.608
2022 Phanse Y, Puttamreddy S, Loy D, Ramirez JV, Ross KA, Alvarez-Castro I, Mogler M, Broderick S, Rajan K, Narasimhan B, Bartholomay LC. RNA Nanovaccine Protects against White Spot Syndrome Virus in Shrimp. Vaccines. 10. PMID 36146509 DOI: 10.3390/vaccines10091428  0.537
2022 Siddoway AC, Verhoeven D, Ross KA, Wannemuehler MJ, Mallapragada SK, Narasimhan B. Structural Stability and Antigenicity of Universal Equine H3N8 Hemagglutinin Trimer upon Release from Polyanhydride Nanoparticles and Pentablock Copolymer Hydrogels. Acs Biomaterials Science & Engineering. PMID 35604784 DOI: 10.1021/acsbiomaterials.2c00219  0.587
2021 Senapati S, Darling RJ, Ross KA, Wannemeuhler MJ, Narasimhan B, Mallapragada SK. Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production. Science Advances. 7. PMID 34348905 DOI: 10.1126/sciadv.abj1691  0.524
2021 Hasibuzzaman MM, Ross KA, Salem AK, Narasimhan B, Simons AL. Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles. Journal of Visualized Experiments : Jove. PMID 34251369 DOI: 10.3791/62683  0.491
2021 Stephens LM, Ross KA, Waldstein KA, Legge KL, McLellan JS, Narasimhan B, Varga SM. Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus. Journal of Immunology (Baltimore, Md. : 1950). PMID 33827894 DOI: 10.4049/jimmunol.2100018  0.607
2020 Grego EA, Siddoway AC, Uz M, Liu L, Christiansen JC, Ross KA, Kelly SM, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles. Current Topics in Microbiology and Immunology. PMID 33165869 DOI: 10.1007/82_2020_226  0.615
2020 Thukral A, Ross K, Hansen C, Phanse Y, Narasimhan B, Steinberg H, Talaat AM. A single dose polyanhydride-based nanovaccine against paratuberculosis infection. Npj Vaccines. 5: 15. PMID 32128256 DOI: 10.1038/s41541-020-0164-y  0.596
2019 Dhakal S, Ghimire S, Renu S, Ross KA, Lakshmanappa YS, Hogshead BT, Bernardo P, Lee CW, Wannemuehler MJ, Narasimhan B, Renukaradhya GJ. Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs. Veterinary Microbiology. 237: 108401. PMID 31585639 DOI: 10.1016/J.Vetmic.2019.108401  0.656
2019 Wafa EI, Geary SM, Ross KA, Goodman JT, Narasimhan B, Salem AK. Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine. Nanomedicine : Nanotechnology, Biology, and Medicine. 102055. PMID 31319179 DOI: 10.1016/J.Nano.2019.102055  0.599
2019 Kingstad-Bakke BA, Chandrasekar SS, Phanse Y, Ross KA, Hatta M, Suresh M, Kawaoka Y, Osorio JE, Narasimhan B, Talaat AM. Effective mosaic-based nanovaccines against avian influenza in poultry. Vaccine. PMID 31300285 DOI: 10.1016/J.Vaccine.2019.06.077  0.627
2019 Banerjee K, Gautam SK, Kshirsagar P, Ross KA, Spagnol G, Sorgen P, Wannemuehler MJ, Narasimhan B, Solheim JC, Kumar S, Batra SK, Jain M. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. Genes & Cancer. 10: 52-62. PMID 31258832 DOI: 10.18632/Genesandcancer.189  0.548
2019 Rintelmann CL, Grinnage-Pulley T, Ross K, Kabotso DEK, Toepp A, Cowell A, Petersen C, Narasimhan B, Pohl N. Design and synthesis of multivalent α-1,2-trimannose-linked bioerodible microparticles for applications in immune response studies of infection. Beilstein Journal of Organic Chemistry. 15: 623-632. PMID 30931004 DOI: 10.3762/Bjoc.15.58  0.58
2019 Espinosa-Cotton M, Rodman Iii SN, Ross KA, Jensen IJ, Sangodeyi-Miller K, McLaren AJ, Dahl RA, Gibson-Corley KN, Koch AT, Fu YX, Badovinac VP, Laux D, Narasimhan B, Simons AL. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma. Journal For Immunotherapy of Cancer. 7: 79. PMID 30890189 DOI: 10.1186/S40425-019-0550-Z  0.472
2019 Ross K, Senapati S, Alley J, Darling R, Goodman J, Jefferson M, Uz M, Guo B, Yoon KJ, Verhoeven D, Kohut M, Mallapragada S, Wannemuehler M, Narasimhan B. Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice. Biomaterials Science. PMID 30663733 DOI: 10.1039/C8Bm01443D  0.633
2018 Wafa EI, Geary SM, Ross KA, Goodman JT, Narasimhan B, Salem AK. Single dose of polyanhydride particle-based vaccine generates potent antigen-specific antitumor immune responses. The Journal of Pharmacology and Experimental Therapeutics. PMID 30361239 DOI: 10.1124/Jpet.118.252809  0.646
2018 Zacharias ZR, Ross KA, Hornick EE, Goodman JT, Narasimhan B, Waldschmidt TJ, Legge KL. Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections. Frontiers in Immunology. 9: 1953. PMID 30233573 DOI: 10.3389/Fimmu.2018.01953  0.622
2018 Sharpe LA, Vela Ramirez JE, Haddadin OM, Ross KA, Narasimhan B, Peppas NA. Correction to "pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles". Biomacromolecules. PMID 30141322 DOI: 10.1021/Acs.Biomac.8B01240  0.59
2018 Sharpe LA, Vela Ramirez JE, Haddadin OM, Ross KA, Narasimhan B, Peppas NA. pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles. Biomacromolecules. PMID 29443509 DOI: 10.1021/Acs.Biomac.7B01590  0.597
2017 Banerjee K, Kumar S, Ross KA, Gautam S, Poelaert B, Nasser MW, Aithal A, Bhatia R, Wannemuehler MJ, Narasimhan B, Solheim JC, Batra SK, Jain M. Emerging trends in the immunotherapy of pancreatic cancer. Cancer Letters. PMID 29242097 DOI: 10.1016/J.Canlet.2017.12.012  0.566
2017 Banerjee K, Gautam S, Nasser WM, Kshirsagar P, Ross K, Spagnol G, Aithal A, Sorgen P, Batra SK, Kumar S, Narasimhan B, Jain M. Abstract 3678: Muc4 nanovaccine and checkpoint blockade based combination immunotherapy for pancreatic cancer Cancer Research. 77: 3678-3678. DOI: 10.1158/1538-7445.Am2017-3678  0.544
2016 Ross K, Adams J, Loyd H, Ahmed S, Sambol A, Broderick S, Rajan K, Kohut M, Bronich T, Wannemuehler MJ, Carpenter S, Mallapragada S, Narasimhan B. Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza. Acs Biomaterials Science & Engineering. 2: 368-374. PMID 33429541 DOI: 10.1021/acsbiomaterials.5b00477  0.611
2016 Ross K, Adams J, Loyd H, Ahmed S, Sambol A, Broderick S, Rajan K, Kohut M, Bronich T, Wannemuehler MJ, Carpenter S, Mallapragada S, Narasimhan B. Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza Acs Biomaterial Science and Engineering. 2: 368-374. DOI: 10.1021/Acsbiomaterials.5B00477  0.647
2015 Ross KA, Brenza TM, Binnebose AM, Phanse Y, Kanthasamy AG, Gendelman HE, Salem AK, Bartholomay LC, Bellaire BH, Narasimhan B. Nano-enabled delivery of diverse payloads across complex biological barriers. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26315817 DOI: 10.1016/J.Jconrel.2015.08.039  0.479
2015 Ross KA, Loyd H, Wu W, Huntimer L, Ahmed S, Sambol A, Broderick S, Flickinger Z, Rajan K, Bronich T, Mallapragada S, Wannemuehler MJ, Carpenter S, Narasimhan B. Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity. International Journal of Nanomedicine. 10: 229-43. PMID 25565816 DOI: 10.2147/Ijn.S72264  0.667
2014 Ross KA, Huntimer LM, Vela Ramirez JE, Adams JR, Carpenter SL, Kohut ML, Bronich T, Webby R, Legge KL, Mallapragadal SK, Wannemuehler MJ, Narasimhan B. Vaccine technologies against avian influenza: current approaches and new directions. Journal of Biomedical Nanotechnology. 10: 2261-94. PMID 25992457 DOI: 10.1166/jbn.2014.1983  0.519
2014 Haughney SL, Ross KA, Boggiatto PM, Wannemuehler MJ, Narasimhan B. Effect of nanovaccine chemistry on humoral immune response kinetics and maturation. Nanoscale. 6: 13770-8. PMID 25285425 DOI: 10.1039/C4Nr03724C  0.677
2014 Ross KA, Haughney SL, Petersen LK, Boggiatto P, Wannemuehler MJ, Narasimhan B. Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours. Advanced Healthcare Materials. 3: 1071-7. PMID 24520022 DOI: 10.1002/Adhm.201300525  0.686
2014 Ross KA, Loyd H, Wu W, Huntimer L, Wannemuehler MJ, Carpenter S, Narasimhan B. Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles. Journal of Biomedical Materials Research. Part A. 102: 4161-8. PMID 24443139 DOI: 10.1002/Jbm.A.35086  0.611
2014 Huntimer LM, Ross KA, Darling RJ, Winterwood NE, Boggiatto P, Narasimhan B, Ramer-Tait AE, Wannemuehler MJ. Polyanhydride nanovaccine platform enhances antigen-specific cytotoxic T cell responses Technology. 2: 171-175. DOI: 10.1142/S2339547814500162  0.57
2014 Haughney S, Ross KA, Boggiatto P, Wannemuehler MJ, Narasimhan B. Pulmonary persistence of intranasally administered polyanhydride nanovaccines Nanoscale Science and Engineering Forum 2013 - Core Programming Area At the 2013 Aiche Annual Meeting: Global Challenges For Engineering a Sustainable Future. 364.  0.388
2013 Huntimer L, Ramer-Tait AE, Petersen LK, Ross KA, Walz KA, Wang C, Hostetter J, Narasimhan B, Wannemuehler MJ. Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery. Advanced Healthcare Materials. 2: 369-78. PMID 23184561 DOI: 10.1002/Adhm.201200181  0.72
2013 Huntimer L, Wilson Welder JH, Ross K, Carrillo-Conde B, Pruisner L, Wang C, Narasimhan B, Wannemuehler MJ, Ramer-Tait AE. Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 101: 91-8. PMID 23143744 DOI: 10.1002/Jbm.B.32820  0.744
Show low-probability matches.